JP2017500030A5 - - Google Patents

Download PDF

Info

Publication number
JP2017500030A5
JP2017500030A5 JP2016538531A JP2016538531A JP2017500030A5 JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5 JP 2016538531 A JP2016538531 A JP 2016538531A JP 2016538531 A JP2016538531 A JP 2016538531A JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5
Authority
JP
Japan
Prior art keywords
acid sequence
seq
set forth
nucleic acid
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016538531A
Other languages
English (en)
Japanese (ja)
Other versions
JP7078350B2 (ja
JP2017500030A (ja
Filing date
Publication date
Priority claimed from PCT/US2013/075137 external-priority patent/WO2014093894A2/en
Application filed filed Critical
Priority claimed from PCT/US2014/070188 external-priority patent/WO2015089492A2/en
Publication of JP2017500030A publication Critical patent/JP2017500030A/ja
Publication of JP2017500030A5 publication Critical patent/JP2017500030A5/ja
Priority to JP2021108614A priority Critical patent/JP2021166534A/ja
Application granted granted Critical
Publication of JP7078350B2 publication Critical patent/JP7078350B2/ja
Priority to JP2023108341A priority patent/JP2023138998A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016538531A 2012-12-13 2014-12-13 Dna抗体構築物及びその使用方法 Active JP7078350B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021108614A JP2021166534A (ja) 2013-12-13 2021-06-30 Dna抗体構築物及びその使用方法
JP2023108341A JP2023138998A (ja) 2012-12-13 2023-06-30 Dna抗体構築物及びその使用方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361896646P 2013-10-28 2013-10-28
PCT/US2013/075137 WO2014093894A2 (en) 2012-12-13 2013-12-13 Dna antibody constructs and method of using same
USPCT/US2013/075137 2013-12-13
PCT/US2014/070188 WO2015089492A2 (en) 2013-12-13 2014-12-13 Dna antibody constructs and method of using same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2020035240A Division JP2020108381A (ja) 2012-12-13 2020-03-02 Dna抗体構築物及びその使用方法
JP2021108614A Division JP2021166534A (ja) 2012-12-13 2021-06-30 Dna抗体構築物及びその使用方法

Publications (3)

Publication Number Publication Date
JP2017500030A JP2017500030A (ja) 2017-01-05
JP2017500030A5 true JP2017500030A5 (enExample) 2018-01-25
JP7078350B2 JP7078350B2 (ja) 2022-05-31

Family

ID=81845563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016538531A Active JP7078350B2 (ja) 2012-12-13 2014-12-13 Dna抗体構築物及びその使用方法

Country Status (1)

Country Link
JP (1) JP7078350B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1213481A1 (zh) * 2012-12-13 2016-07-08 The Trustees Of The University Of Pennsylvania Dna抗体构建体及其使用方法
GB201704417D0 (en) 2017-03-20 2017-05-03 Univ Copenhagen Improved li vaccine adjuvant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709224B2 (en) 2003-06-03 2010-05-04 Biosante Pharmaceuticals, Inc. Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
WO2006017325A2 (en) * 2004-07-13 2006-02-16 Cell Genesys, Inc. Aav vector compositions and methods for enhanced expression of immunoglobulins the same
WO2010043977A2 (en) 2008-10-13 2010-04-22 Institute For Research In Biomedicine Dengue virus neutralizing antibodies and uses thereof

Similar Documents

Publication Publication Date Title
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
WO2015188132A8 (en) Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof
JP2016529229A5 (enExample)
EA201792573A1 (ru) Триспецифические связанные белки и способы их применения
JP2016053091A5 (enExample)
EA201400568A1 (ru) Альбуминсвязывающие антитела и их связывающие фрагменты
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
CR20230026A (es) Proteínas de fusión gdf15 y usos de estas (divisional 2018-0532)
IL288541B (en) Vaccine against rsv
JP2013107899A5 (enExample)
EA201491049A1 (ru) Противораковый слитый белок
JP2015212284A5 (enExample)
JP2016501535A5 (enExample)
BR112015020315A2 (pt) conjugação de anticorpo-fármaco sítio-específica por glicoengenharia
JP2017537621A5 (enExample)
RU2017114673A (ru) Слитый белок, наночастица, состоящая из множества мономеров указанного слитого белка, и их применение
JP2014510519A5 (enExample)
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
PL393578A1 (pl) Przeciwnowotworowe białko fuzyjne
PE20181956A1 (es) Polipeptidos que inhiben cd40l
CA3018427C (en) Adenoviral coat protein derived delivery vehicles
NZ769391A (en) Serpin fusion polypeptides and methods of use thereof
CY1117283T1 (el) Σταθερα μονομερη και ολιγομερη αμυλοειδους βητα
MX381726B (es) Cadena alfa del receptor de inmunoglobulina e (ige) de alta afinidad de fusion de fragmento cristalizable (fc).